Related Experiment Video
Updated: Sep 15, 2025

Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells
Published on: June 16, 2023
The role of long noncoding RNA SNHG29 in malignant tumors
Tingcheng Bu1, Wendong Gu2, Yingjie Shao3
1Department of Radiation Oncology, The Third Affiliated Hospital of Soochow University, 185 Juqian Street, Changzhou, 213003, China.
Abstract:
Long noncoding RNAs (lncRNAs), defined as noncoding transcripts exceeding 200 nucleotides without protein-coding potential, have been increasingly recognized for encoding polipeptides or proteinsimplicated in the regulation of malignant tumor initiation, progression, and prognosis. Among them, small nucleolar RNA host gene 29 (SNHG29) has attracted increasing attention because of its aberrant expression across diverse malignancies. This report reviews the latest research regarding its expression patterns, regulatory functions, and involved signaling pathways. This review synthesizes current insights into the contributions of SNHG29 to oncogenic processes, including cell proliferation, migration, epithelial‒mesenchymal transition, chemoresistance, and immunosuppression. Furthermore, evidence indicates that SNHG29 functions as a competing endogenous RNA (ceRNA), modulating tumor progression via the miRNA‒mRNA axis and signaling pathways such as the ATR‒Chk1, PI3K‒AKT, and Wnt‒β-catenin pathways. Cumulative data position SNHG29 as a promising diagnostic and prognostic biomarker, as well as a potential molecular target for therapeutic intervention in various malignancies.
Insights
Small nucleolar RNA host gene 29 (SNHG29) is a long noncoding RNA (lncRNA) implicated in various cancers. Research highlights its role in tumor progression and potential as a diagnostic and therapeutic target.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Long noncoding RNAs (lncRNAs) are increasingly recognized for their roles in cancer.
- Small nucleolar RNA host gene 29 (SNHG29) shows aberrant expression in multiple malignancies.
Purpose of the Study:
- To review current research on SNHG29 expression, functions, and regulatory pathways in cancer.
- To synthesize insights into SNHG29's contribution to oncogenic processes.
Main Methods:
- Literature review of recent studies on SNHG29 in malignancies.
- Analysis of SNHG29's involvement in cell proliferation, migration, EMT, chemoresistance, and immunosuppression.
- Examination of SNHG29's function as a competing endogenous RNA (ceRNA) and its associated signaling pathways.
Main Results:
- SNHG29 contributes to key oncogenic processes including proliferation, migration, and chemoresistance.
- SNHG29 acts as a ceRNA, regulating tumor progression through miRNA-mRNA interactions.
- SNHG29 influences critical signaling pathways like ATR-Chk1, PI3K-AKT, and Wnt-β-catenin.
Conclusions:
- SNHG29 plays a significant role in diverse cancer types.
- SNHG29 is a potential diagnostic and prognostic biomarker for malignancies.
- SNHG29 represents a promising molecular target for cancer therapy.
More Related Videos
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Related Concept Videos
lncRNA - Long Non-coding RNAs
MicroRNAs
RNA Splicing
Abnormal Proliferation
Non-LTR Retrotransposons